What's in UroGen Pharma Ltd.'s pipeline?

UroGen Pharma Ltd. has 5 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with UroGen Pharma Ltd.'s portfolio?

Top competitors by shared drug class: Abivax S.A., Akorn, Inc., Guangdong Hengrui Pharmaceutical Co., Ltd, Health Research, Inc., Imperial College London.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/urogen-pharma-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

UroGen Pharma Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

UroGen Pharma Ltd. pipeline: 0 marketed, 0 filed, 3 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
UGN-103	UGN-103	phase 3	Small molecule	Not publicly disclosed	Oncology
UGN-104	UGN-104	phase 3	Thymidine analog	Thymidine synthase	Oncology
UGN-102	UGN-102	phase 3	Intravesical chemotherapy agent	DNA (mitomycin C mechanism)	Oncology

Therapeutic area mix

Oncology · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Abivax S.A. · 1 shared drug class
Akorn, Inc. · 1 shared drug class
Guangdong Hengrui Pharmaceutical Co., Ltd · 1 shared drug class
Health Research, Inc. · 1 shared drug class
Imperial College London · 1 shared drug class
Jiangsu HengRui Medicine Co., Ltd. · 1 shared drug class
Nanjing Sanhome Pharmaceutical, Co., Ltd. · 1 shared drug class
Pfizer · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for UroGen Pharma Ltd.:

Cite this brief

Drug Landscape (2026). UroGen Pharma Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/urogen-pharma-ltd. Accessed 2026-06-10.